EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Clinical significance of PNO1 as a novel biomarker and therapeutic target of hepatocellular carcinoma

Sanjit K Roy, Shivam Srivastava, Caroline McCance, Anju Shrivastava, Jason Morvant, Sharmila Shankar iD, Rakesh K Srivastava iD

Journal of Cellular and Molecular Medicine · 2024

DOI: 10.1111/jcmm.18295 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, 2024. Verfasst von Sanjit K Roy und 6 weiteren Autor:innen. Beteiligte Einrichtung: Stanley S. Scott Cancer Center, School of Medicine, Louisiana State University Health, New Orleans, Louisiana, USA. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Biomarkers, Tumor, Gene Expression Regulation, Neoplastic. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 82 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The RNA‐binding protein PNO1 plays an essential role in ribosome biogenesis. Recent studies have shown that it is involved in tumorigenesis; however, its role in hepatocellular carcinoma (HCC) is not well understood. The purpose of this study was to examine whether PNO1 can be used as a biomarker of HCC and also examine the therapeutic potential of PNO1 knockout for the treatment of HCC. PNO1 expression was upregulated in HCC and associated with poor prognosis. PNO1 expression was positively associated with tumour stage, lymph node metastasis and poor survival. PNO1 expression was significantly higher in HCC compared to that in fibrolamellar carcinoma or normal tissues. Furthermore, HCC tissues with mutant Tp53 expressed higher PNO1 than those with wild‐type Tp53. PNO1 knockout suppressed cell viability, colony formation and EMT of HCC cells. Since activation of Notch signalling pathway promotes HCC, we measured the effects of PNO1 knockout on the components of Notch pathway and its targets. PNO1 knockout suppressed Notch signalling by modulating the expression of Notch ligands and their receptors, and downstream targets. PNO1 knockout also inhibited genes involved in surface adhesion, cell cycle, inflammation and chemotaxis. PNO1 knockout also inhibited colony and spheroid formation, cell migration and invasion, and markers of stem cells, pluripotency and EMT in CSCs. Overall, our data suggest that PNO1 can be used as a diagnostic and prognostic biomarker of HCC, and knockout of PNO1 by CRISPR/Cas9 can be beneficial for the management of HCC by targeting CSCs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsBiomarkers, TumorGene Expression Regulation, NeoplasticRNA-Binding ProteinsHumansMaleCell Line, TumorFemalePrognosisMiddle AgedSignal TransductionTumor Suppressor Protein p53Receptors, NotchCell MovementNeoplastic Stem CellsEpithelial-Mesenchymal TransitionCell ProliferationClinical Relevance

Stichwörter der Autor:innen

CRISPR/Cas9PNO1biogenesiscancer stem cellhepatocellular carcinomanotch

Substanzen

Biomarkers, TumorRNA-Binding ProteinsTumor Suppressor Protein p53Receptors, Notch

Autor:innen und Institutionen

  • Stanley S. Scott Cancer Center, School of Medicine, Louisiana State University Health, New Orleans, Louisiana, USA.
  • Louisiana State University, Baton Rouge, Louisiana, USA.
  • Department of Cellular and Molecular Biology, Tulane University, New Orleans, Louisiana, USA.
  • St. Joseph's Hospital and Medical Center, Phoenix, Arizona, USA.
  • Department of Surgery, Ochsner Health System, Gretna, Louisiana, USA.
  • Southeast Louisiana Veterans Health Care System, New Orleans, Louisiana, USA.

ORCID-Profile: Sharmila Shankar, Rakesh K Srivastava

Zitieren

APA

Roy, S. K., Srivastava, S., McCance, C., Shrivastava, A., Morvant, J., Shankar, S., & Srivastava, R. K. (2024). Clinical significance of PNO1 as a novel biomarker and therapeutic target of hepatocellular carcinoma. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.18295

Vancouver

Roy SK, Srivastava S, McCance C, Shrivastava A, Morvant J, Shankar S, et al. Clinical significance of PNO1 as a novel biomarker and therapeutic target of hepatocellular carcinoma. Journal of Cellular and Molecular Medicine. 2024. doi:10.1111/jcmm.18295

BibTeX
@article{Roy2024,
  author = {Roy, Sanjit K and Srivastava, Shivam and McCance, Caroline and Shrivastava, Anju and Morvant, Jason and Shankar, Sharmila and Srivastava, Rakesh K},
  title = {Clinical significance of PNO1 as a novel biomarker and therapeutic target of hepatocellular carcinoma},
  journal = {Journal of Cellular and Molecular Medicine},
  year = {2024},
  doi = {10.1111/jcmm.18295}
}
Kostenlos starten →